These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 28535400)

  • 1. Comparison of the cervista HPV HR test and luminex XMAP technology for the diagnosis of cervical intraepithelial neoplasia.
    Zhao PY; Jiang HC; Li Y; Wang JB; Zhang TT; Liu CH; Song LW; Cheng JJ
    Eur J Obstet Gynecol Reprod Biol; 2017 Jul; 214():150-155. PubMed ID: 28535400
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of careHPV, Cervista Human Papillomavirus, and Hybrid Capture 2 Methods in Diagnosing Cervical Intraepithelial Neoplasia Grade 2+ in Xinjiang Uyghur Women.
    Tuerxun G; Yukesaier A; Lu L; Aierken K; Mijiti P; Jiang Y; Abulizi A; Zhang Y; Abuduxikuer G; Abulizi G; Li H
    Oncologist; 2016 Jul; 21(7):825-31. PubMed ID: 27317575
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of The Cervista HPV A9 group In Screening Patients for Cervical Cancer.
    Zhao J; Du H; Belinson JL; Qu X; Zhang W; Mei J; Yang B; Wang C; Zhang L; Wu R
    J Med Screen; 2016 Mar; 23(1):38-43. PubMed ID: 26466824
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical performance characteristics of the Cervista HPV HR test kit in cervical cancer screening in China.
    Zhao J; Zhang X; Ma J; Liu G; Yao D; Zhang W; Wang J; Wei L; Zhao Y; Zeng Y; Liao Q
    J Low Genit Tract Dis; 2012 Oct; 16(4):358-63. PubMed ID: 23023138
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immediate histopathologic follow-up of cervista and aptima high-risk HPV assays in women with LSIL cytology.
    Zhang H; Varma KR; Han M; Matsko J; Zhao C
    Cancer Cytopathol; 2018 Aug; 126(8):525-532. PubMed ID: 29797678
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of the Aptima and Cervista tests for detection of high-risk human papillomavirus in cervical cytology specimens.
    Nolte FS; Ribeiro-Nesbitt DG
    Am J Clin Pathol; 2014 Oct; 142(4):561-6. PubMed ID: 25239425
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Application of Cervista® human papilloma virus high-risk test in cervical cancer screening of Xinjiang Uyghur women.
    Zhang YY; Mijit F; Abliz G; Zhang L
    Eur J Gynaecol Oncol; 2016 Aug; 37(4):484-487. PubMed ID: 29894071
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cervista HPV HR test for cervical cancer screening: a comparative study in the Catalonian population.
    Alameda F; Garrote L; Mojal S; Sousa C; Muset M; LLoveras B; Bellosillo B; Saldanha C; Carreras R; Serrano S
    Arch Pathol Lab Med; 2015 Feb; 139(2):241-4. PubMed ID: 25611107
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Performance of human papillomavirus typing test in cervical precancer lesions and cervical cancer screening].
    Zhang SK; Luo XP; Li ZF; Su Z; Xia JC; Hu GY; Zhu YJ; Xie LX; Feng XX; Sun XB; Chen W; Qiao YL
    Zhonghua Zhong Liu Za Zhi; 2020 Mar; 42(3):252-256. PubMed ID: 32252206
    [No Abstract]   [Full Text] [Related]  

  • 10. A population-based observational study comparing Cervista and Hybrid Capture 2 methods: improved relative specificity of the Cervista assay by increasing its cut-off.
    Boehmer G; Wang L; Iftner A; Holz B; Haedicke J; von Wasielewski R; Martus P; Iftner T
    BMC Infect Dis; 2014 Dec; 14():674. PubMed ID: 25487281
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical validation of the Cervista HPV HR and 16/18 genotyping tests for use in women with ASC-US cytology.
    Einstein MH; Martens MG; Garcia FA; Ferris DG; Mitchell AL; Day SP; Olson MC
    Gynecol Oncol; 2010 Aug; 118(2):116-22. PubMed ID: 20488510
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Validation of cobas 4800 HPV assay in SurePath Papanicolaou specimens for cervical cancer screening.
    Guo M; Shlyakhova N; Khanna A; Tinnirello AA; Schmeler KM; Hwang J; Sturgis EM; Stewart J
    J Am Soc Cytopathol; 2021; 10(4):399-405. PubMed ID: 33967024
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Screening properties of human papillomavirus testing for predicting cervical intraepithelial neoplasia in atypical squamous cells of undetermined significance and low-grade squamous intraepithelial lesion smears: a prospective study.
    Dane C; Batmaz G; Dane B; Cetin A
    Ann Diagn Pathol; 2009 Apr; 13(2):73-7. PubMed ID: 19302953
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Age-stratified performance of the Cervista HPV 16/18 genotyping test in women with ASC-US cytology.
    Einstein MH; Garcia FA; Mitchell AL; Day SP
    Cancer Epidemiol Biomarkers Prev; 2011 Jun; 20(6):1185-9. PubMed ID: 21527581
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Combining high-risk human papillomavirus DNA test and cytological test to detect early cervical dysplasia].
    Qian DY; Cen JM; Wang D; Zeng RH; Lin AH; Shu YH; Hong DH; Huang ZH
    Zhonghua Fu Chan Ke Za Zhi; 2006 Jan; 41(1):34-7. PubMed ID: 16635326
    [TBL] [Abstract][Full Text] [Related]  

  • 16. PCR-reverse dot blot human papillomavirus genotyping as a primary screening test for cervical cancer in a hospital-based cohort.
    Kang Y; Sun P; Mao X; Dong B; Ruan G; Chen L
    J Gynecol Oncol; 2019 May; 30(3):e29. PubMed ID: 30887754
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Triage of women with negative cytology and positive high-risk HPV: an analysis of data from the SHENCCAST II/III studies.
    Goodrich SK; Pretorius RG; Du H; Wu R; Belinson JL
    J Low Genit Tract Dis; 2014 Apr; 18(2):122-7. PubMed ID: 24270196
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rate of detection of high-risk HPV with two assays in women ≥ 30 years of age.
    Quigley NB; Potter NT; Chivukula M; Knight MZ; Welch JR; Olson MC
    J Clin Virol; 2011 Sep; 52(1):23-7. PubMed ID: 21724457
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Performance of carcinogenic human papillomavirus (HPV) testing and HPV16 or HPV18 genotyping for cervical cancer screening of women aged 25 years and older: a subanalysis of the ATHENA study.
    Castle PE; Stoler MH; Wright TC; Sharma A; Wright TL; Behrens CM
    Lancet Oncol; 2011 Sep; 12(9):880-90. PubMed ID: 21865084
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human papillomavirus (HPV) E6/E7 mRNA as a triage test after detection of HPV 16 and HPV 18 DNA.
    Perez Castro S; Iñarrea Fernández A; Lamas González MJ; Sarán Diez MT; Cid Lama A; Alvarez Martín MJ; Pato Mosquera M; López-Miragaya I; Estévez N; Torres Piñón J; Oña Navarro M
    J Med Virol; 2013 Jun; 85(6):1063-8. PubMed ID: 23588733
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.